100 compounding pharmacies are registered with FDA as 503B outsourcing facilities as of November 17, 2026. FDA has inspected 57 of them as outsourcing facilities and issued a Form 483 after 56 of those inspections; the median report lists 5 observations.
Each facility has a page with its registration dates, its last inspection, what the inspectors observed and any FDA warning letter about GLP-1 drugs that names it. Every fact comes from FDA’s list and the reports FDA posted with it.1
Is the pharmacy behind my prescription on FDA’s list?
Type a pharmacy name or city. A 503A pharmacy that compounds for individual prescriptions is licensed by its state and is not on this list.
🔎Pharmacy check100 facilities
Registered 503B—
With a Form 483—
Where are they?
Texas has the most registered facilities, 17, followed by Florida with 16.
What does it mean that a pharmacy is a 503B outsourcing facility?
An outsourcing facility is a compounder that has chosen to register with FDA under section 503B of the Federal Food, Drug, and Cosmetic Act. It must re-register every year between October 1 and December 31 and pay an annual fee; a facility that does not is removed from FDA’s list on January 1.1 Once registered, it joins the list of facilities FDA plans to inspect on a risk-based schedule.1
A Form FDA 483 lists what investigators observed during an inspection. FDA states that a 483 is issued when investigators see significant objectionable conditions, and that it is not a final agency determination that the law was broken.1 Registration is not FDA approval of the drugs a facility makes: compounded drugs are not FDA-approved.
How was this list built?
On November 20, 2026 we read FDA’s table of registered outsourcing facilities, updated November 17, 2026, downloaded each Form 483 FDA links from it, and counted the observations in each report. We sorted observations into topics by the words of their opening sentence. The contact names and phone numbers in FDA’s table are left out. Nothing here comes from other review sites.
Sources
FDA. Facilities registered as human drug compounding outsourcing facilities under section 503B, updated November 17, 2026, with its notes on registration and inspections. fda.gov
📱 Log every dose in mg with the vial it came from, so there is a record if something goes wrong.